أعضاء هيئة التدريس - جامعة بنها
CHA2DS2-VASc-HS score for prediction of adverse inhospital outcomes in patients with non-ST segment elevation myocardial infarction
• 2021
معلومات البحث
المؤلفون
M.K.Mahmoud, H.M.Kabil, H.H.Ebed and A.M.Sabry
الكلمات المفتاحية
Not Available
المجلة العلمية
Not Available
الناشر
Not Available
المجلد
Not Available
العدد
Not Available
الصفحات
Not Available
publication.type
Local
رابط البحث
Not Available
المواد المرفقة
Not Available
الملخص
For a treatment choice the early identification of non-ST myocardial infarction segment patients
(NSTEMI) with poor in-hospital results is essential. The CHA2DS2-VASc-HS and CHA2DS2-VASc
score was recently reported as a predictor of severity and poor outcomes in individuals with stable
coronary artery disease (CAD) and acute coronary syndrome. Our research aimed at evaluating the
precision of the CHA2DS2-VASc-HS score, which predicts poor outcomes in hospitals in NSTEMI
patients. 120 NSTEMI patients have been enrolled. The score for CHA2DS2-VASc-HS has been
computed. The participants of the research were split into two groups. Group I and Group II score 4. Patients with CHA2DS2-VASc-HS >4
were found to have higher unfavourable outcomes in the hospital than the CHA2DS2-VASc-HS score
(NSTEMI) with poor in-hospital results is essential. The CHA2DS2-VASc-HS and CHA2DS2-VASc
score was recently reported as a predictor of severity and poor outcomes in individuals with stable
coronary artery disease (CAD) and acute coronary syndrome. Our research aimed at evaluating the
precision of the CHA2DS2-VASc-HS score, which predicts poor outcomes in hospitals in NSTEMI
patients. 120 NSTEMI patients have been enrolled. The score for CHA2DS2-VASc-HS has been
computed. The participants of the research were split into two groups. Group I and Group II score 4. Patients with CHA2DS2-VASc-HS >4
were found to have higher unfavourable outcomes in the hospital than the CHA2DS2-VASc-HS score